Global Hemoglobin A1C Testing Market Forecast to 2028 - Advancements in POCT for Accurate, Affordable, and User-friendly HbA1c Testing

News provided by

Dec 01, 2023, 06:15 ET

DUBLIN, Dec. 1, 2023 /PRNewswire/ -- The "Global Hemoglobin A1C Testing Market, Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

The global hemoglobin A1C (HbA1c) testing market will witness significant growth driven by technological advances and the increasing adoption of point-of-care testing (POCT). Real-time glucose monitoring and conventional HbA1c testing have been integrated, revolutionizing patient care by offering better treatment choices and better results.

By streamlining data collection, this integration improves operational effectiveness in healthcare settings. POCT options play a significant role as well, offering on-the-spot HbA1c testing for rapid outcomes and prompt action, further improving patient satisfaction and saving valuable assets.

Collaborations between medical device manufacturers, healthcare IT businesses, and pharmaceutical companies determine the competitive landscape in the HbA1c testing market. By promoting industrial convergence and the development of integrated solutions, these partnerships position companies as market leaders with cutting-edge products.

Companies that capitalize on this trend early on have an advantage over competitors and create new business prospects by addressing the rising need for all-inclusive diabetes management products.

Key Topics Covered:

HbA1c Testing Overview

Key Competitors
Global Diabetes Highlights, 2021
Number of People with Diabetes, 2021-2045
Top 10 Countries or Territories for Number of Adults
Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast Analysis
Revenue Forecast by Region
Revenue Forecast By Setting
Revenue Forecast by End Users
Revenue Forecast by Technology
Pricing Trends and Analysis
Key Pricing Strategies Adopted by Players
Future Aspect of Pricing
Global HbA1c Testing Market - Notable Activities
Global HbA1c Testing Reimbursement Pathways
Competitive Environment

Companies to Watch - Lab and POC HbA1c Testing

Abbott Laboratories
Roche Diagnostics
Siemens Healthineers
Beckman Coulter
Tosoh Corporation
Bio-Rad Laboratories
EKF Diagnostics
Erba Diagnostics, Inc.
Diazyme Laboratories
PTS Diagnostics
Trinity Biotech
Competitive Mapping by HbA1c Offering Parameters

Growth Opportunity Summary

Growth Opportunity 1 - Tailoring HbA1c Testing Approaches to Individual Patient Characteristics
Growth Opportunity 2 - Advancements in POCT for Accurate, Affordable, and User-friendly HbA1c Testing
Growth Opportunity 3 - Capturing Opportunities in Growing Diabetes Care Markets
Growth Opportunity 4 - Diabetes HbA1c Screening for Better Care and Management

For more information about this report visit https://www.researchandmarkets.com/r/nac9vf

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets